Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
25,001 - 50,000 - Monthly Reach
Unique listeners across all episodes (30 days)
75,001 - 150,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 11 epsHosts
Recent guests
Recent episodes
The First Environmental GE Organism Release - almost! Dr. Steven Lindow
Apr 28, 2026
25m 47s
New Frontiers in Therapeutic Peptides - Dr. Karsten Eastman
Apr 16, 2026
33m 19s
Genetic Variation in Vegetative Propagation - Dr. Danelle Seymour
Apr 1, 2026
28m 22s
Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh
Feb 27, 2026
46m 30s
A Plasmid-Based Cancer Therapy - Dr. Alexander Schneider
Feb 17, 2026
44m 40s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/28/26 | The First Environmental GE Organism Release - almost! Dr. Steven Lindow✨ | genetic engineeringbiotechnology+3 | Dr. Steven Lindow | Talking BiotechColabra | — | ice minus bacteriafrost damage+3 | — | 25m 47s | |
| 4/16/26 | New Frontiers in Therapeutic Peptides - Dr. Karsten Eastman✨ | therapeutic peptidesGLP-1 therapeutics+4 | Dr Karsten Eastman | GLP-1 therapeuticspeptide-based therapies+3 | — | Sathera Therapeuticspeptide-based therapies+1 | — | 33m 19s | |
| 4/1/26 | Genetic Variation in Vegetative Propagation - Dr. Danelle Seymour✨ | genetic variationvegetative propagation+5 | Dr Danelle Seymour | Talking BiotechWashington Naval | — | genetic anomaliestree crops+2 | — | 28m 22s | |
| 2/27/26 | Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh✨ | conditionally active biologicsimmuno-oncology+3 | Dr Neela PatelDr Diane Hollenbaugh | Talking BiotechBonum Therapeutics+1 | — | Bonum Therapeuticsmarket landscape+1 | — | 46m 30s | |
| 2/17/26 |  A Plasmid-Based Cancer Therapy - Dr. Alexander Schneider✨ | cancer therapyimmunotherapy+2 | Dr Alexander Schneider | ElanogenTalking Biotech+1 | — | ElanogenP62 protein+3 | — | 44m 40s | |
| 2/2/26 | Biotech in Beauty Products - Nicholas Brideau✨ | biotechnologybeauty industry+6 | Nicholas Brideau | carmineDebut Biotech products+1 | — | biotechcosmetics+2 | — | 1h 10m 17s | |
| 1/24/26 | Molecular Biology Giants that Left Us In 2025✨ | molecular biologyDNA science+1 | — | — | — | 2025contributions+1 | — | 1h 10m 17s | |
| 12/27/25 | TB Throwback- Correcting the Veritasium Episode on Glyphosate✨ | glyphosaterisk assessment+1 | — | VeritassiumVeritasium | — | Veritasiumcontroversy+1 | — | 1h 11m 45s | |
| 12/20/25 | TB Throwback: Gliblastoma and Cindy's Gift✨ | glioblastomacancer research+1 | Dr Shiela SinghDr Thomas Graham | — | — | Cindy's Giftglioblastoma research+1 | — | 1h 04m 24s | |
| 12/13/25 | TB Throwback: Dr. Avindra Nath and HERV-based Diseases✨ | human endogenous retrovirusesdisease+1 | Dr Avindra Nath | NIH | — | NIHproteins+1 | — | 50m 36s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 12/6/25 | 482 Dr. Maxine Thompson, Episode 117, Jan 18, 2015✨ | plant breedinginterview+1 | Dr Maxine Thompson | — | — | — | — | 37m 40s | |
| 11/2/25 | A Biotech Probiotic to Enhance Fiber - Dr. Zack Abbott | In this episode of the Talking Biotech podcast, Dr. Kevin Folta and Dr. Zack Abbott discuss the critical role of dietary fiber in human health, the alarming statistics regarding fiber deficiency in the population, and the innovative solutions being developed by Zbiotics to address this issue. They delve into the science behind genetically engineered probiotics that can convert sugars into fiber, enhancing gut health and microbiome diversity. The conversation also touches on future possibilities for probiotic technology and its potential to solve modern health challenges. | 35m 42s | ||||||
| 10/19/25 | Peer Review and Rigor in Controversial Science - Cam English, Dr. Liza Lockwood | This cross-platform podcast is shared on Science Facts and Fallacies as well as Talking Biotech. Cameron English, Dr. Liza Lockwood and Dr. Kevin Folta discuss the comments made during a rant on the Science Facts and Fallacies podcast concerning the rigor of peer review and alledged lack of self policing in academic publishing. They discuss several papers in the recent public eye, with an emphasis on the process, the media response, and the nuance that is used in academic publishing, review and editorial oversight. | 55m 21s | ||||||
| 10/11/25 | Everyone Else is Lying to You - Pandemic Disinformation - Dr. Jonathan Howard | In this episode of the Talking Biotech podcast, Dr. Jonathan Howard discusses his experiences during the COVID-19 pandemic, the rise of disinformation, and the anti-vaccine movement. He reflects on his role as a physician at Bellevue Hospital, the impact of misinformation on public health, and the key players who have influenced the narrative surrounding vaccines and COVID-19. Dr. Howard emphasizes the need for the medical community to stand against misinformation and the importance of engaging in public discourse to restore trust in science and public health institutions. | 49m 36s | ||||||
| 10/5/25 | Targeting RNA with Therapeutics - Dr. Matthew Disney | SummaryIn this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics. | 41m 36s | ||||||
| 9/27/25 | Biotech Takes On the Screw Worm - Dr. Max Scott | In this episode of the Talking Biotech podcast, Dr. Max Scott discusses the significant threat posed by screw worms, a parasitic insect that lays eggs in live animals, leading to severe economic and health impacts on livestock. The conversation covers the historical eradication efforts using the sterile insect technique, the current resurgence of screw worms in North America, and the innovative biotechnology approaches being explored to control their populations, including gene drive technology. The episode also addresses the public perception of genetic technologies in agriculture and the importance of continuous monitoring and advocacy for effective pest management. | 36m 04s | ||||||
| 9/20/25 | Attacking Cancers through Neoantigens - Dr. Jackie Douglass | In this episode of the Talking Biotech podcast, Dr. Jackie Douglas discusses the emerging field of neoantigens and their significance in cancer immunotherapy. Neoantigens, which are unique to cancer cells, offer a promising target for personalized immunotherapies. The conversation covers the formation of neoantigens, the role of HLA alleles in their presentation, recent advances in research, and various therapeutic strategies being explored. Challenges such as patient response variability and the need for affordable treatments are also highlighted, along with the potential for future developments in the field. | 34m 21s | ||||||
| 9/13/25 | Drug Discovery in the Synapse - Derek Small | In this episode of the Talking Biotech podcast, Dr. Kevin Folta interviews Derek Small, co-founder and CEO of Syndeoo, focusing on the increasing prevalence of neurological disorders and the challenges in developing effective therapies. They discuss the importance of synaptic function in mental health and neurodegenerative diseases, the innovative Boost platform for drug development, and the potential of event-driven pharmacology. The conversation highlights the hope for new treatments in the pipeline for conditions like depression and Alzheimer's disease. | 42m 48s | ||||||
| 9/6/25 | Correcting the Veratasium Glyphosate - Monsanto Episode | Listener Request! The YouTube channel Veritasium has been recognized by scientists and the public as a great source for scientific information. So what happened in the recent episode? The episode originally entitled "Exposing the Monsanto Conspiracy" attempts to link the historic horrors of Agent Orange and contaminated herbicides with current claims against the herbicide glyphosate. To build the story this science channel relies on horrible sources and poor scholarship to build the illogical conclusion that because a company had a bad past, and anti-biotech activists and money-hungry lawyers build a narrative, then the herbicide must cause cancer. This, despite the overwhelming consensus from independent research and regulatory bodies that says there is no evidence of carcinogenicity at dietary or occupational exposure levels. This episode is designed to help the scientific listener understand the actual evidence and how even traditionally good communications efforts can become vehicles for anti-scientific campaigns. | 1h 09m 00s | ||||||
| 8/23/25 | Unintended Effects of HPV and Shingles Vaccines - Dr. Kevin Folta | Anti-vaccination activists, including the US Health and Human Services Secretary, decry the risk of vaccination. In two recently developed vaccines the emerging story is that there is risk in not being vaccinated. Analysis of large data sets shows that over the last 20 years, those vaccinated with the HPV vaccine have a lower incidence of cervical, penile and anal cancers, as they should. But they also show lower incidence of other cancers as well, such as lung, blood and nervous system cancers. The shingles vaccines seem to have protective effects against dementia, heart disease and stroke. All of thse findings suggest that broader vaccination may have public health benefit. More importantly, these may be strategies against vaccine hesitancy, as families don't remember the sourge of polio and measles, but they likely know someone with cancer or dementia. These findings could be a way to nucleate a shift in vaccine perception among evidence deniers.HPV and Other Cancers: https://www.sciencedirect.com/science/article/pii/S1043661825002762Shingles vaccine and dementia: https://www.nature.com/articles/s41586-025-08800-xShingles vaccine and cardiovascular disease: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf440/8229580Singles vaccine and cardiovascular disease: https://academic.oup.com/eurheartj/article/46/30/2991/8124786 | 22m 23s | ||||||
| 8/16/25 | Revolutionizing Agriculture with RNA Technology - Dr. Andrey Zarur | In this episode of the Talking Biotech podcast, Dr. Andrey Zarur, CEO of Greenlight Biosciences, discusses the innovative applications of RNA technology in agriculture. The conversation covers the challenges of food security, the role of RNA in pest control, and the regulatory advantages of RNA-based products. Dr. Zarur highlights the efficacy and safety of RNA insecticides, fungicides, and herbicides, as well as the company's efforts to address bee health. The discussion also touches on public perception and the importance of transparent communication in biotechnology.00:00Introduction to RNA and Its Role in Agriculture02:02Challenges in Global Food Production05:07The Promise of RNA Technology10:05Regulatory Landscape for RNA-Based Solutions13:52Stability and Application of RNA Products18:00Product Development and Efficacy of RNA Pesticides19:48Targeting Specific Pests with RNA Technology26:51AI in RNA Design and Future Prospects30:01Innovative Approaches to Pest Control32:41Targeting Specific Pests with RNA Technology35:22Challenges in Regulatory Approval and Public Perception38:02Engaging with the Public and NGOs42:46Addressing the Varroa Mite Crisis in Beekeeping49:18Developing RNA Solutions for Weed Management | 58m 22s | ||||||
| 8/9/25 | Glyphosate 10 Years After IARC - Dr. Robert Tarone | SummaryIn this episode of the Talking Biotech podcast, Dr. Kevin Folta interviews Dr. Robert Tarone, a retired scientist with extensive experience in cancer statistics and experimental design. They discuss the controversial IARC monograph that classified glyphosate as a probable human carcinogen, the flaws in the evaluation process, and the implications of this classification on legal actions against glyphosate manufacturers. Dr. Tarone critiques the evidence used by IARC, emphasizing the lack of credible data linking glyphosate to cancer, and highlights the importance of rigorous scientific methodology in evaluating such claims. | 50m 41s | ||||||
| 8/2/25 | Glyphosate: 10 Lessons from 10 Years After IARC - Dr. David Zaruk | In this episode of the Talking Biotech podcast, Kevin Folta and Dr. David Zaruk discuss the complexities surrounding glyphosate, particularly in light of the IARC Monograph 112 published a decade ago. They explore the implications of the reclassification of glyphosate as a probable carcinogen, the ensuing litigation, influence and corruption, and the ethical concerns regarding scientific integrity. The conversation delves into the role of the media, the influence of litigation finance, and the future of glyphosate in agriculture, emphasizing the need for transparency and evidence-based discussions over jury decisions. | 1h 06m 37s | ||||||
| 7/26/25 | Evidence of Pig Domestication - Dr. Jiajing Wang | This conversation explores the domestication of pigs, highlighting their importance in human society, the historical evidence of their domestication, and innovative research methods used to study their relationship with humans. Dr. Jiajing Wang from Dartmouth College discusses the significance of dental calculus in elucidaing pig diets and behaviors, as well as the complex interactions between humans and pigs throughout history. | 32m 24s | ||||||
| 7/19/25 | The Shingles Vaccines and Dementia - Dr. Pascal Geldsetzer | In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Dr. Pascal Geldsetzer about the relationship between the shingles vaccine and dementia. They discuss the prevalence of shingles, the current vaccination rates, and the potential implications of shingles vaccination on cognitive decline. The data come from a clever analysis of public health data that revealed this surprising result. Dr. Geldsetzer shares insights from his research, which suggests that the shingles vaccine may significantly reduce the risk of developing dementia. The conversation also covers the methodology behind the research, findings from various populations, and future directions for further studies in this area. | 25m 15s | ||||||
Showing 25 of 486
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
19 placements across 18 markets.
Chart Positions
19 placements across 18 markets.